Shares in Elevance Health (NYSE: ELV) slumped over 8% on Thursday after the health insurance provider’s second-quarter earnings and full-year guide missed analyst estimates. The company reported Q2 ...

FUCHS released preliminary second-quarter 2025 key figures on Wednesday after market close, showing results that fell short of analyst expectations. Shares are still up 0.6%. The company’s revenue ...